Article
Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research
2022-03-03
Abstract excerpt
<h4>Introduction</h4> A major challenge to enabling precision health at a global scale is the bias between those who enroll in state sponsored genomic research and those suffering from chronic disease. More than 30 million people have been genotyped by direct-to-consumer (DTC) companies such as 23andMe, Ancestry DNA, and MyHeritage, providing a potential mechanism for democratizing access to medical interventions...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- afaa5e3a-79e4-5fd2-a745-bc918efba406
- DOI
- 10.1101/2022.03.01.22271722
